Sexual dimorphism is observed in the progression to congestive heart failure and, ultimately, in longevity in spontaneously hypertensive heart failure (SHHF) rats. As platelet activation may impact development of cardiovascular diseases, we studied the effects of obesity and sex on platelet polyunsaturated fatty acid (PUFA) profile and its relationship to platelet aggregation in 6-month-old SHHF rats. After a 24-hr fast, blood was obtained for measurement of platelet phospholipid omega-6 (n-6) and omega-3 (n-3) PUFA. Collagen-induced platelet aggregation was measured by whole-blood impedance aggregometry. Obese male (OM) SHHF had significantly more platelet arachidonic acid (AA) and total n-6 PUFA than lean males (LMs), lean females (LFs), or obese females (OFs). Platelet aggregation was enhanced in males compared to females, with OMs by 45% compared to OFs and with LMs by 28% compared to LFs. Though no difference was found between OFs and LFs, platelet agregation was increased in OMs by 20% compared to LMs. Though not significantly different, lag time to initiate platelet aggregation tended to be shortest in OMs and then, in Increasing duration, LMs, LFs, and OFs, suggesting that Platelets from male rats were quicker to aggregate than those from females. Platelet aggregation was correlated with platelet AA and total n-6 PUFA content. There was no relationship between n-3 PUFA and platelet aggregation. In SHHF rats, elevated AA and n-6 PUFA levels in platelets are associated with Chanced platelet aggregation. This relationship is potentiated by obesity and male sex.
FikeCD, KaplowitzMR, PfisterSL. Arachidonic acid metabolites and an early stage of pulmonary hypertension in chronically hypoxic newborn pigs. Am J Physiol Lung Cell Mol Physiol284: L316–323, 2003.
2.
RomanRJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev82: 131–185, 2002.
3.
RussoC, OlivieriO, GirelliD, GuariniP. Increased membrane ratios of metabolite to precursor fatty acid in essential hypertension. Hypertension29: 1058–1063, 1997.
TaylorAA. Pathophysiology of hypertension and endothelial dysfunction in patients with diabetes mellitus. Endocrinol Metab Clin North Am30: 983–997, 2001.
ReillyM, FitzgeraldGA. Cellular activation by thromboxane A2 and other eicosanoids. Eur Heart J14(Suppl K): 88–93, 1993.
8.
SchrorK, BraunM. Platelets as a source of vasoactive mediators. Stroke21(Suppl):IV32–35, 1990.
9.
GurbelPA, GattisWA, FuzaylovSF, GauldenL. Evaluation of platelets in heart failure: is platelet activity related to etiology. functional class or clinical outcomes? Am Heart J143: 1068–1075, 2002.
10.
HodgsonWC, SikorskiBW, KingRG. Cardiovascular sensitivity changes to eicosanoids in rats with experimentally induced diabetes mellitus. Clin Exp Pharmacol Physiol19: 9–15, 1992.
11.
IsenseeH, JacobR. Differential effects of various oil diets on the risk of cardiac arrhythmias in rats. J Cardiovasc Risk1: 353–359, 1994.
12.
SchrorK. The effect of prostaglandins and thromboxane A2 on coronary vessel tone–mechanisms of action and therapeutic implications. Eur Heart J14(Suppl I): 34–41, 1993.
13.
DaviG, GuagnanoMT, CiabattoniG, BasiliS, FalcoA, MarinopiccoliM, NutiniM, SensiS, PatronoC. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA288: 2008–2014, 2002.
14.
HaszonI, PappF, KovacsJ, BorsM, NemethI, BereczkiC, TuriS. Platelet aggregation, blood viscosity and serum lipids in hypertensive and obese children. Eur J Pediatr162: 385–390, 2003.
15.
HorrobinDF. Abnormal membrane concentrations of 20 and 22-carbon essential fatty acids: a common link between risk factors and coronary and peripheral vascular disease?Prostaglandins Leukot Essent Fatty Acids53: 385–396, 1995.
16.
MandaiS, SarodeR, DashS, DashRJ. Hyperaggregation of platelets detected by whole blood platelet aggregometry in newly diagnosed noninsulin-dependent diabetes mellitus. Am J Clin Pathol100: 103–107, 1993.
SavicaV, BellinghieriG, BarberaCM, EgittoM, ConsoloF. The coagulative system in haemodialyzed patients: the relationship between the elderly and hypertrygliceridaemia. Arch It UrolLXIV: 155–163, 1992.
VericelE, CalzadaC, ChapuyP, LagardeM. The influence of low intake of n-3 fatty acids on platelets in elderly people. Atherosclerosis147: 187–192, 1999.
21.
VericelE, LagardeM, DechavanneM, CourpronP. Increased lipid Peroxidation in platelets from elderly people. Thromb Haemost54: 553, 1985.
22.
McCuneSA, JenkinsJE, StillsHF, ParkS, RadinMJ, JurinRR, HamlinRE. Renal and heart function in the SHHF/Mcc-cp rat. In: Frontiers in Diabetes Research. Lessons from Animal Diabetes III. London: Smith Gordon, pp 397–401, 1990.
23.
McCuneSA, RadinMJ, JenkinsJE, ChuYY, ParkS, PetersonRG. SHUF/Mcc-facp rat model: effects of gender and genotype on age of expression of metabolic complications and congestive heart failure and on response to drug therapy. In: Frontiers in Diabetes Research. Lessons from Animal Diabetes V. London: Smith Gordon, pp 255–270, 1995.
24.
RadinMJ, HolycrossBJ, HoepfTM, McCuneSA. Increased salt sensitivity secondary to leptin resistance in SHHF rats is mediated by endothelin. Mol Cell Biochem242: 57–63, 2003.
25.
RadinMJ, HolycrossBJ, SharkeyLC, ShiryL, McCuneSA. Gender modulates activation of renin-angiotensin and endothelin systems in hypertension and heart failure. J Appl Physiol92: 935–940, 2002.
26.
FriedmanJE, FerraraCM, AulakKS, HatzoglouM, McCuneSA, ParkS, ShermanWM. Exercise training down-regulates ob gene expression in the genetically obese SHHF/Mcc- facp rat. Horm Metab Res29: 214–219, 1997.
27.
IshizukaT, ErnsbergerP, LiuS, BedolD, LehmanTM, KoletskyRJ, FriedmanJE. Phenotypic consequences of a nonsense mutation in the leptin receptor gene (fak) in obese spontaneously hypertensive Koletsky rats (SHROB). J Nutr128: 2299–2306, 1998.
28.
HoverslandRC. Onset of obesity and puberty in genetically obese SHHF/Mcc-cp rats. Int J Obesity16: 977–984, 1992.
29.
McCuneSA, BakerPB, StillsHF. SHHF/Mcc-cp rat: model of obesity, non-insulin dependent diabetes, and congestive heart failure. ILAR News32: 23–27, 1990.
30.
DeFronzoRA, FerranniniE. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care14: 173–194, 1991.
31.
McCuneS, ParkS, RadinM, JurinR. SHHF/Mcc-facp rat model: a genetic model of congestive heart failure. In: Mechanisms of Heart Failure. Dordrecht, The Netherlands: Kluwer Academic Publishers, pp 91–106, 1995.
32.
HolycrossBJ, SummersBM, DunnRB, McCuneSA. Plasma renin activity in heart failure-pronè SHHF/Mcc-facp rats. Am J Physiol273: H228–233, 1997.
33.
SharkeyLC, HolycrossBJ, McCuneSA, RadinMJ. Obese female SHHF/Mcc-facp rats resist antihypertensive effects of renin-angiotensin system inhibition. Clin Exp Hypertension23: 227–239, 2001.
34.
SharkeyLC, HolycrossBJ, ParkS, McCuneSA, HoverslandR, RadinMJ. Effect of ovariectomy in heart failure prone SHHF-Mcc-facp rats. Am J Physiol275: R1968–1976, 1998.
35.
MendelsohnME, KarasRH. The protective effects of estrogen on the cardiovascular system. New Eng J Med340: 1801–1811, 1999.
36.
RadinMJ, JenkinsJE, McCuneSA, JurinRR, HamlinRL. Effects of enalapril and Clonidine on glomerular structure, function, and atrial natriuretic peptide receptors in SHHF/Mcc-cp rats. J Cardiovasc Pharmacol19: 464–472, 1992.
37.
ParkS, McCuneSA, RadinMJ, HoepfTM, HensleyJ, HohlCM, AltschuldRA. Verapamil accelerates the transition to heart failure in obese, hypertensive, female SHHF/Mcc-facp rats. J Cardiovasc Pharmacol29: 726–733, 1997.
38.
KwonJS, SnookJT, WardlawGM, HwangDH. Effects of diets high in saturated fatty acids, canola oil, or safflower oil on platelet function, thromboxane B2 formation, and fatty acid composition of platelet phospholipids. Am J Clin Nutr54: 351–358, 1991.
39.
FolchJ, LeeM, StanleyGHS. A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem226: 497–509, 1957.
40.
ChristieWW. The isolation of lipids from tissues. In: Lipid Analysis (2nd ed.). New York: Pergamon Press, pp 17–24, 1982.
41.
NakamuraMT, TangAB, VillanuevaJ, HalstedCH, PhinneySD. Selective reduction of delta-6 and delta-5 desaturase activities but not delta-9 desaturase in micro pigs chronically fed ethanol. J Clin Invest93: 450–454, 1994.
42.
MorrisonWR, SmithLM. Preparation of fatty acid methylesters and dimethyl acetals from lipids with boron fluoride with boron fluoride methanol. J Lipids Res5: 600–608, 1964.
43.
MedeirosLC, LiuYW, ParkS, ChangPH, SmithAM. Insulin, but not estrogen, correlated with indexes of desaturase function in obese women. Horm Metab Res27: 235–238, 1995.
44.
MoritaI, TakahashiR, ItoH, OrimoH, MurotaS. Increased arachidonic acid content in platelet phospholipids from diabetic patients. Prostaglandins Leukot Med11: 33–41, 1983.
45.
MyrupB, BregengaardC, PetersenLR, WintherK. Platelet aggregation and fatty acid composition of platelets in type 1 diabetes mellitus. Clin Chim Acta204: 251–261, 1991.
46.
PhinneySD. Arachidonic acid maldistribution in obesity. Lipids31(Suppl):S271–S274, 1996.
47.
PerezC, RamiroJM, CampilloJE. Increased arachidonic acid uptake by platelets from insulin-dependent diabetics and diabetic rats. Diabetes Res Clin Pract7: 69–73, 1989.
48.
TakahashiR, MoritaI, SaitoY, ItoH, MurotaS. Increased arachidonic acid incorporation into platelet phospholipids in type 2 (non-insulin-dependent) diabetes. Diabetologia26: 134–137, 1984.
49.
TretjakovsP, KalninsU, DabinaI, ErglisA, DinneI, JurkaA, LatkovskisG, ZvaigzneA, PiragsV. Nitric oxide production and arachidonic acid metabolism in platelet membranes of coronary heart disease patients with and without diabetes. Med Prin Pract12: 10–16, 2003.
50.
MarraCA, de AlanizMJT, BrennerRR. Effect of various steroids on the biosynthesis of arachidonic acid in isolated hepatocytes and HTC cells. Lipids23: 1053–1058, 1988.
51.
ChenSY, YuBJ, LiangYQ, LinWD. Platelet aggregation, platelet cAMP levels and thromboxane B2 synthesis in patients with diabetes mellitus. Chin Med J103: 312–318, 1990.
52.
HalushkaPV, MayfieldR, ColwellJA. Insulin and arachidonic acid metabolism in diabetes mellitus. Metabolism34(12 Suppl 1): 32–36, 1985.
FitzgeraldGA, CatellaF, OatesJA. Eicosanoid biosynthesis in human cardiovascular disease. Hum Pathol18: 248–252, 1987.
57.
GarciaRLA. The effect of NSAIDs on the risk of coronary heart disease: fusion of clinical pharmacology and pharmacoepidemiologic data. Clin Exp Rheumatol19(6 Suppl 25): S41–44, 2001.
58.
SobolAB, WatalaC. The role of platelets in diabetes-related vascular complications. Diabetes Res Clin Pract50: 1–16, 2000.
59.
AgrenJJ, HanninenO, HanninenA, SeppanenK. Dose responses in platelet fatty acid composition, aggregation and prostanoid metabolism during moderate freshwater fish diet. Thromb Res57: 565–575, 1990.
60.
HiraiA, TeranoT, HamazakiT, SajikiJ, KondoS, OzawaA, FujitaT, MiyamotoT, TamuraY, KumagaiA. The effects of the oral administration of fish oil concentrate on the release and the metabolism of [14C]arachidonic acid and [14C]eicosapentaenoic acid by human platelets. Thromb Res28: 285–298, 1982.
61.
MurrayMJ, ZhangT. The incorporation of dietary n-3 polyunsaturated fatty acids into porcine platelet phospholipids and their effects on platelet thromboxane A2 release. Prostaglandins Leukot Essent Fatty Acids56: 223–228, 1997.
62.
von HouwelingenAC, ThorngrenM, HornstraG, BornGV. Release of thromboxane A2 and beta-thromboglobulin during in-vivo plug formation following standardized skin incisions: effect of a moderate fish intake. Thromb Haemost67: 713–717, 1992.
63.
CrosetM, VericelE, RigaudM, HanssM, CourpronP, DechavanneM, LagardeM. Function and tocopherol content of blood platelets from elderly people after low intake of purified eicosapentaenoic acid. Thromb Res57: 1–12, 1990.
64.
DrissF, VericelE, LagardeM, DechavanneM, DarcetP. Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid. Thromb Res36: 389–396, 1984.
65.
GibneyMJ, Bolton-SmithC. The effect of a dietary supplement of n-3 polyunsaturated fat on platelet lipid composition, platelet function and platelet plasma membrane fluidity in healthy volunteers. Br J Nutr60: 5–12, 1988.
66.
LiuY, MedeirosLC. Platelet aggregation, serum and platelet fatty acids in three generations of women. Nutr Res15: 831–842, 1995.
67.
RiessH, MerkW, FalknerC, HillerE. Increased in vitro platelet aggregation in hypertriglyceridemias. Thromb Res41: 281–289, 1986.
68.
AokiI, AokiN, KawanoK, ShimoyamaK, MakiA, HomoriM, YanagisawaA, YamamotoM, KawaiY, IshikawaK. Platelet-dependent thrombin generation in patients with hyperlipidemia. J Am Coll Cardiol30: 91–96, 1997.
69.
KonstantinidesS, SchaferK, LoskutoffDJ. The prothrombotic effects of leptin possible implications for the risk of cardiovascular disease in obesity. Ann N Y Acad Sci947: 134–141, 2001.
70.
KonstantinidesS, SchaferK, KoschnickS, LoskutoffDJ. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for artherothrombotic disease in obesity. J Clinc Invest108: 1533–1540, 2001.
71.
MaruyamaI, NakataM, YamajiK. Effect of leptin in platelet and endothelial cells. Obesity and arterial thrombosis. Ann N Y Acad Sci. 902: 315–319, 2000.
72.
NakataM, YadaT, SoejimaN, MaruyamaI. Leptin promotes aggregation of human platelets via the long form of its receptor. Diabetes48: 426–429, 1999.
73.
OzataM, AveuF, DurmusO, YilmazI, OzdemirIC, YalcinA. Leptin does not play a major role in platelet aggregation in obesity and leptin deficiency. Obes Res9: 627–630, 2001.
74.
GobelBO, Schulte-GobelA, WeisserB, GlanzerK, VetterH, DusingR. Arterial blood pressure. Correlation with erythrocyte count, hematocrit, and hemoglobin concentration. Am J Hypertens4: 14–19, 1991.
75.
SaxenaS, WongET. Heterogeneity of common hematologic parameters among racial, ethnic, and gender subgroups. Arch Pathol Lab Med114: 715–719, 1990.
76.
MooreDM. Hematology of the rat. In: FeldmanBF, ZinklJG, JainNC, Eds. Schalm's Veterinary Hematology. Philadelphia, PA: Lippincott, Williams & Wilkins, pp 1210–1218, 2000.
